A leading biotechnology startup from Toronto's University Health Network (UHN) has raised US$60-million form some of the biggest U.S. investors in the sector to help develop its cutting-edge cancer detection technology. Adela Inc. is a diagnostic company that aims to identify multiple types of cancers and other conditions with a simple blood test.
